Physician profile
Michael Lee
NPI 1053993626
$2,910.96
in general payments reported to CMS, 2019-2025
13 companies · $2,563 in 2025
The $2,563 reported for 2025 was more than what 98% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $223 · 2025: $2,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,565 · Grant: $1,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,564.96 |
| Grant | $1,346.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,346.00 | 2025 | Assurity, Tacticath, Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $400.96 | 2023-2025 | Eliquis, Camzyos |
| Amgen INC. | $237.04 | 2024-2025 | Repatha, Repatha |
| Atricure, INC. | $233.29 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $220.63 | 2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $124.99 | 2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $120.53 | 2025 | |
| Abiomed | $83.31 | 2025 | |
| Baxter Healthcare | $56.60 | 2025 | Floseal |
| Boston Scientific Corporation | $28.60 | 2025 | Watchman Flx |
| Heartflow, INC. | $22.83 | 2025 | |
| Kestra Medical Technology Services, INC. | $19.33 | 2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $16.85 | 2025 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.